Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Zintellect
- National University of Singapore
- Nanyang Technological University
- City of Hope
- University of Maryland, Baltimore
- Dana-Farber Cancer Institute (DFCI)
- University of Oslo
- Harvard University
- Office of the Commissioner (OC)
- The University of Queensland
- University of Nottingham
- University of Otago
- Cold Spring Harbor Laboratory
- Eisbach Bio GmbH
- Faculdade de Ciências da Universidade de Lisboa
- H. Lee Moffitt Cancer Center & Research Institute
- Hong Kong Polytechnic University
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- National Center for Toxicological Research (NCTR)
- Nottingham Trent University
- QUEENS UNIVERSITY BELFAST
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- The Infinity Fellowship
- The University of Edinburgh;
- The University of Southampton
- The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
- UNIVERSITY OF HELSINKI
- UiT The Arctic University of Norway
- University College London
- University College London (UCL)
- University of Agder
- University of Cincinnati
- University of Colorado
- University of Idaho
- University of Leeds
- University of Leeds;
- University of London
- University of Michigan
- University of Michigan - Ann Arbor
- University of South-Eastern Norway
- 30 more »
- « less
-
Field
-
, antimicrobial resistance, inspection and laboratory capacity, good clinical practices, and good regulatory practices. Learning Objectives: Throughout the fellowship, you will engage in structured learning
-
heterogeneity, translational fitness, and drug resistance to Targeted Pol I therapy. We are seeking a highly motivated and enthusiastic candidate with strong communication and interpersonal skills, capable
-
treatment and diagnostic information. The aim of these efforts is to identify genomic alterations and transcriptional changes associated with tumor evolutionary dynamics, mechanisms of resistance, and
-
the molecular mechanisms driving cancer progression, treatment resistance, and tumor microenvironment interactions. The role will involve designing and conducting experiments, analyzing complex datasets
-
resistance. The postholder will also unlock the molecular events leading to the pathogen crossing the intestinal barrier. The work leverages in vivo and ex vivo models (gut organoids, fully differentiated
-
foundation in cancer biology and a passion for advancing our understanding of cancer progression and treatment resistance. With expertise spanning molecular and cellular biology techniques, you are eager
-
disease resistance, quality, and nutritional value. The role will contribute to linking metabolite composition with genetic variation and gene expression, enabling the discovery of key regulatory mechanisms
-
on cancer progression, therapeutic resistance, tumor-immune interactions, or molecular oncology, depending on expertise. The role also involves collaboration with clinical and translational research teams
-
limited to: Whole-genome sequencing and single-cell sequencing analysis of tumor samples Studies of resistance to existing and emerging cancer therapies using patient-derived data Studies of patient samples
-
openings for the new ventilation system. Assess the performance of the optimized panel (mechanical resistance, air permeability, acoustic performance). Optimize the ventilation system's configuration